Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Betahistine dihydrochloride
Cat. No.:
OB0225LY-0175
Appearance:
Liquid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Betahistine dihydrochloride is a histamine analog and H1 receptor agonist.
Synonym:
PT-9; Betahistine 2HCl; 5579-84-0; 2-Pyridineethanamine, N-methyl-, dihydrochloride; 2-(2-(Methylamino)ethyl)pyridine dihydrochloride; N-Methyl-N-(2-pyridin-2-ylethyl)amine dihydrochloride; Methyl[2-(pyridin-2-yl)ethyl]amine dihydrochloride; N-methyl-2-pyridin-2-ylethanamine dihydrochloride; N-Methyl-2-pyridin-2-ylethanamine dihydrochloride
CAS No.:
5579-84-0
Compound CID:
68643
Formula:
C8H14Cl2N2
Formula Weight:
209.12
Specification
Relative Density:
0.967 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Betahistine dihydrochloride can be used for ear disease research.
Library Information
Targets:
Histamine receptor
Receptors:
H3 receptor
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-3
Plate Location:
b8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 239.1 mM
Water Max Solubility:
35 mg/mL; 167.4 mM
Ethanol Max Solubility:
1 mg/mL; 4.78 mM
